Simply Wall Street .
Caplin Point Laboratories shows strong EPS growth at 21% annually over three years, coupled with 11% revenue growth to ₹20b.
Insiders hold 69% of shares, aligning interests with shareholders; CEO compensation is modest at ₹5.7m, below industry median ₹48m.